You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南微醫學(688029.SH):減持期屆滿 張博及芮晨累計減持1.2萬股
格隆匯 03-12 18:14

格隆匯3月12日丨南微醫學(688029.SH)公佈,本次減持計劃實施前,公司董事、高級副總裁張博持有公司股份60萬股,佔公司總股本的比例為0.4500%;公司高級副總裁、財務負責人芮晨為持有公司股份40萬股,佔公司總股本的比例為0.3000%。

公司於2020年8月22日披露《南微醫學科技股份有限公司股東及董監高減持股份計劃公吿》,公司董事、高級副總裁張博擬通過集中競價方式減持公司股份不超過15萬股,不超過公司總股本比例0.1125%。公司高級副總裁、財務負責人芮晨為擬通過集中競價方式減持公司股份不超過10萬股,不超過公司總股本比例0.0750%。

公司於2021年3月12日分別收到張博、芮晨為《關於減持實施結果的吿知函》,本次減持計劃區間已屆滿,截至本公吿披露日,張博以集中競價方式減持公司股份2000股,佔公司總股本的0.0015%;芮晨為以集中競價方式減持公司股份1萬股,佔公司總股本的0.0075%。本次減持計劃期間已屆滿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account